PT Kalbe Farma Tbk.
Symbool: PTKFY
PNK
17.03
USDMarktprijs vandaag
0.0056
Koers/Winst Verhouding
0.0000
Koers/Winst Groei Verhouding
3.94B
MRK Kapitalisatie
- 0.03%
DIV Rendement
PT Kalbe Farma Tbk. (PTKFY) Jaarrekeningen
Balans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 3397916.9 | 263.9 | 455.6 | |||||
balance-sheet.row.short-term-investments | 0 | 165496.3 | 9.4 | 18.2 | |||||
balance-sheet.row.net-receivables | 0 | 5628331.7 | 308.5 | 249.4 | |||||
balance-sheet.row.inventory | 0 | 6791979.8 | 460 | 363.3 | |||||
balance-sheet.row.other-current-assets | 0 | 99495.7 | 44.4 | 37.2 | |||||
balance-sheet.row.total-current-assets | 0 | 15917724.1 | 1076.8 | 1105.6 | |||||
balance-sheet.row.property-plant-equipment-net | 0 | 8537934.7 | 535.8 | 586.3 | |||||
balance-sheet.row.goodwill | 0 | 479347.4 | 30.9 | 14.8 | |||||
balance-sheet.row.intangible-assets | 0 | 1327234.2 | 1066868.8 | 961154.4 | |||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1806581.6 | 1546216.2 | 1170837.9 | |||||
balance-sheet.row.long-term-investments | 0 | 285302.3 | 24.8 | 21.3 | |||||
balance-sheet.row.tax-assets | 0 | 136102.6 | 8.2 | 6.5 | |||||
balance-sheet.row.other-non-current-assets | 0 | 373922.8 | -1546106.4 | -1170751.6 | |||||
balance-sheet.row.total-non-current-assets | 0 | 11139844.1 | 678.6 | 700.4 | |||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.total-assets | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.account-payables | 0 | 1690719.6 | 128.7 | 117.3 | |||||
balance-sheet.row.short-term-debt | 0 | 299759.4 | 55.1 | 6.6 | |||||
balance-sheet.row.tax-payables | 0 | 225196.6 | 13.8 | 19 | |||||
balance-sheet.row.long-term-debt-total | 0 | 318778.9 | 18.5 | 34.5 | |||||
Deferred Revenue Non Current | 0 | 0 | 1.6 | 3 | |||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||
balance-sheet.row.other-current-liab | 0 | 1252689.5 | 87.9 | 105.7 | |||||
balance-sheet.row.total-non-current-liabilities | 0 | 694377.6 | 45.9 | 60.9 | |||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.capital-lease-obligations | 0 | 41907.5 | 1.6 | 3 | |||||
balance-sheet.row.total-liab | 0 | 3937546.2 | 331.5 | 309.7 | |||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||
balance-sheet.row.common-stock | 0 | 468751.2 | 30.2 | 33 | |||||
balance-sheet.row.retained-earnings | 0 | 21162752.5 | 1300.8 | 1299.5 | |||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 53.5 | 49.4 | 47.7 | |||||
balance-sheet.row.other-total-stockholders-equity | 0 | -212700.7 | -66.9 | -2.5 | |||||
balance-sheet.row.total-stockholders-equity | 0 | 21418856.5 | 1313.6 | 1377.7 | |||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 27057568.2 | 1755.4 | 1806 | |||||
balance-sheet.row.minority-interest | 0 | 1701165.5 | 110.3 | 118.7 | |||||
balance-sheet.row.total-equity | 0 | 23120022 | 1423.9 | 1496.3 | |||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||
Total Investments | 0 | 450798.6 | 34.1 | 39.6 | |||||
balance-sheet.row.total-debt | 0 | 618538.4 | 75.2 | 44.1 | |||||
balance-sheet.row.net-debt | 0 | -2613882.2 | -179.3 | -393.3 |
Kasstroomoverzicht
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 181.1 | 228.4 | 222.4 | |||||
cash-flows.row.depreciation-and-amortization | 0 | 47.9 | 49.4 | 47.1 | |||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||
cash-flows.row.change-in-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-receivables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.inventory | 0 | 0 | 0 | 0 | |||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-working-capital | 0 | 0 | 0 | 0 | |||||
cash-flows.row.other-non-cash-items | 0 | -35.9 | -191.1 | -68.6 | |||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.acquisitions-net | 0 | 63609.6 | -44.9 | 82.8 | |||||
cash-flows.row.purchases-of-investments | 0 | -173704.2 | -8.6 | -17.5 | |||||
cash-flows.row.sales-maturities-of-investments | 0 | 4.7 | 16.7 | 8.5 | |||||
cash-flows.row.other-investing-activites | 0 | 148275.5 | -0.3 | 0 | |||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1140786.7 | -95.9 | 3.8 | |||||
cash-flows.row.debt-repayment | 0 | -2513595.4 | -24.2 | -35.4 | |||||
cash-flows.row.common-stock-issued | 0 | 0 | -2.6 | 0 | |||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -67.7 | 0 | |||||
cash-flows.row.dividends-paid | 0 | -1757714.4 | -110.2 | -91.7 | |||||
cash-flows.row.other-financing-activites | 0 | 35572 | 44.6 | -6 | |||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -2443986.3 | -160 | -133.1 | |||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | -40050.4 | 237776.4 | -16432.5 | |||||
cash-flows.row.net-change-in-cash | 0 | -717348.3 | -182.9 | 65.7 | |||||
cash-flows.row.cash-at-end-of-period | 0 | 3232420.6 | 254.5 | 437.4 | |||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3949768.9 | 437.4 | 371.7 | |||||
cash-flows.row.operating-cash-flow | 0 | 193.1 | 86.8 | 200.9 | |||||
cash-flows.row.capital-expenditure | 0 | -1178972.2 | -58.8 | -69.9 | |||||
cash-flows.row.free-cash-flow | 0 | -1178779.2 | 28 | 131 |
Rij winst-en-verliesrekening
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | |||
---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 30449134.1 | 1953.9 | 1834.5 | |||||
income-statement-row.row.cost-of-revenue | 0 | 18625888.5 | 1189.7 | 1073.3 | |||||
income-statement-row.row.gross-profit | 0 | 11823245.5 | 764.2 | 761.2 | |||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||
income-statement-row.row.research-development | 0 | - | - | - | |||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.other-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.operating-expenses | 0 | 8198108.5 | 481.4 | 483.3 | |||||
income-statement-row.row.cost-and-expenses | 0 | 26823997 | 1671.1 | 1556.5 | |||||
income-statement-row.row.interest-income | 0 | 88217.6 | 5.5 | 7.7 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||
income-statement-row.row.total-other-income-expensenet | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||
income-statement-row.row.other-operating-expenses | 0 | -6.3 | -15 | -15.6 | |||||
income-statement-row.row.total-operating-expenses | 0 | -66015.4 | 18.3 | 11.5 | |||||
income-statement-row.row.interest-expense | 0 | 82958.2 | 3.7 | 4 | |||||
income-statement-row.row.depreciation-and-amortization | 0 | 333650.2 | 49.4 | 47.1 | |||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||
income-statement-row.row.operating-income | 0 | 3672252.6 | 282.8 | 277.9 | |||||
income-statement-row.row.income-before-tax | 0 | 3606237.2 | 301.1 | 289.4 | |||||
income-statement-row.row.income-tax-expense | 0 | 827832.4 | 68.1 | 63.7 | |||||
income-statement-row.row.net-income | 0 | 2766748 | 228.4 | 222.4 |
Vaak gestelde vragen
Wat is PT Kalbe Farma Tbk. (PTKFY) totale activa?
PT Kalbe Farma Tbk. (PTKFY) totale activa is 27057568182323.000.
Wat is de jaarlijkse omzet van de onderneming?
De jaarlijkse omzet is N/A.
Wat is de winstmarge van de onderneming?
De bedrijfswinstmarge is 0.370.
Wat is vrije kasstroom van de onderneming?
De vrije kasstroom is {free_cash_flow}}.
Wat is de nettowinstmarge van de onderneming?
De nettowinstmarge is 0.089.
Wat is de totale omzet van de onderneming?
De totale opbrengst is 0.123.
Wat is PT Kalbe Farma Tbk. (PTKFY) nettowinst (netto-inkomen)?
De nettowinst is 2766748040055.000.
Wat is de totale schuld van het bedrijf?
De totale schuld is 618538351178.000.
Wat zijn de bedrijfskosten?
De bedrijfsuitgaven zijn 8198108504360.000.
Wat is het kasstroomcijfer van het bedrijf?
Enretprise cash is 0.000.